Breakout Ventures is an early-stage investor focused on life sciences, biology, and chemistry-driven technologies that aim to advance human health and sustainability. The firm backs research-based startups at the intersection of biology, chemistry, and technology, helping them reach critical milestones to build value and scale science-driven solutions. Its portfolio includes cancer immunotherapies, clinical diagnostics, gene editing approaches, and sustainable bioproducts, reflecting a commitment to transformative science. The network emphasizes diverse perspectives and hands-on support for entrepreneurs throughout the journey from seed to scale.
No recent news for this company.